This is also supported by the recent finding that SOX2 repression is an early driver of gliomagenesis that blocks the differentiation of neural stem cells in an in-vitro model of low-grade astrocytomas [76]. Here, SOX2 is linked to astrocytoma (excluding glioblastoma).